The role of peripheral blood stem cells as rescue after myeloablative therapy.
Reiffers
J
J
Unité de Greffe, Hôpital Haut Levêque, Pessac, France.
Marit
G
G
Boiron
J M
JM
Rice
A
A
Bernard
P
P
Vezon
G
G
D000677:Amsacrine / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001803:Blood Transfusion; D003131:Combined Modality Therapy; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D005069:Evaluation Studies as Topic; D006085:Graft Survival; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007937:Leukapheresis; D015470:Leukemia, Myeloid, Acute / Q000097:blood / Q000188:drug therapy / Q000628:therapy*; D008223:Lymphoma / Q000628:therapy; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000628:therapy; D012074:Remission Induction; D014182:Transplantation, Autologous
D000677:Amsacrine; D003561:Cytarabine; D003630:Daunorubicin